Suppr超能文献

直肠膨出的腹腔镜修复术还是经肛门修复术?直肠膨出大小缩小情况的比较。

Laparoscopic or transanal repair of rectocele? Comparison of a reduction in rectocele size.

作者信息

Tsunoda Akira, Takahashi Tomoko, Matsuda Satoshi, Kusanagi Hiroshi

机构信息

Department of Gastroenterological Surgery, Kameda Medical Center, 929 Higashi-cho, Kamogawa City, Chiba, 296-8602, Japan.

出版信息

Int J Colorectal Dis. 2023 Mar 29;38(1):85. doi: 10.1007/s00384-023-04373-1.

Abstract

PURPOSE

This study aimed to compare the reduction in rectocele size after laparoscopic ventral rectopexy (LVR) with that after transanal repair (TAR).

METHODS

Forty-six patients with rectocele who underwent LVR and 45 patients with rectocele who received TAR between February 2012 and December 2022 were included. This was a retrospective analysis of prospectively collected data. All patients had clinical evidence of a symptomatic rectocele. Bowel function was evaluated using the constipation scoring system (CSS) and fecal incontinence severity index (FISI). Substantial symptom improvement was defined as at least a 50% reduction in the CSS or FISI scores. Evacuation proctography was performed before surgery and 6 months postoperatively.

RESULTS

Constipation was substantially improved in 40-70% of the LVR patients and 70-90% of the TAR patients over 5 years. Fecal incontinence was markedly improved in 60-90% of the LVR patients across 5 years and in 75% of the TAR patients at 1 year. Postoperative proctography showed a reduction in rectocele size in the LVR patients (30 [20-59] mm preoperatively vs. 11 [0-44] mm postoperatively, P < 0.0001) and TAR patients (33 [20-55] mm preoperatively vs. 8 [0-27] mm postoperatively, P < 0.0001). The reduction rate of rectocele size in the LVR patients was significantly lower than that in the TAR patients (63 [3-100] % vs. 79 [45-100] %, P = 0.047).

CONCLUSION

The reduction in rectocele size was lower in the patients who underwent LVR than in those who received TAR.

摘要

目的

本研究旨在比较腹腔镜腹直肌固定术(LVR)与经肛门修复术(TAR)后直肠膨出大小的缩小情况。

方法

纳入2012年2月至2022年12月期间接受LVR的46例直肠膨出患者和接受TAR的45例直肠膨出患者。这是对前瞻性收集数据的回顾性分析。所有患者均有症状性直肠膨出的临床证据。使用便秘评分系统(CSS)和大便失禁严重程度指数(FISI)评估肠道功能。症状显著改善定义为CSS或FISI评分至少降低50%。术前和术后6个月进行排粪造影。

结果

在5年期间,40%-70%的LVR患者和70%-90%的TAR患者便秘得到显著改善。在5年期间,60%-90%的LVR患者和1年时75%的TAR患者大便失禁明显改善。术后排粪造影显示,LVR患者(术前30[20-59]mm vs.术后11[0-44]mm,P<0.0001)和TAR患者(术前33[20-55]mm vs.术后8[0-27]mm,P<0.0001)的直肠膨出大小均减小。LVR患者直肠膨出大小的缩小率显著低于TAR患者(63[3-100]% vs. 79[45-100]%,P=0.047)。

结论

接受LVR的患者直肠膨出大小的缩小程度低于接受TAR的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验